Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome

https://doi.org/10.21744/ijhms.v5n1.1811

Authors

  • O. M. Rakhmonov Urologist, Urologic Complex Clinic, Uzbekistan
  • A. K. Shadmanov Doctor of Medical Sciences, Professor, Rector, Tashkent Medical Academy, Uzbekistan
  • F. M. Juraev Oncologist, Urologic Complex Clinic, Uzbekistan

Keywords:

holmium enucleation, intraoperative blood loss, metabolic syndrome, prostatic hyperplasia, transurethral resection

Abstract

The present paper is about the research conducted on the patients with metabolic syndrome and its results of endoscopic treatment of benign prostatic hyperplasia in these patients. It is generally accepted that the size and volume of the prostate gland is the main prognostic factor affecting the intraoperative and postoperative outcomes of endoscopic treatment of BPH. However, with the rapid development of endoscopic instruments and surgical techniques, the size of the prostate tends to have a lesser influence on the outcome of endoscopic BPH treatment. Currently, MS is becoming an increasingly common disease, which in most cases predicts a poor prognosis for treatment of patients with LUTS.

Downloads

Download data is not yet available.

References

Anson, K., Nawrocki, J., Buckley, J., Fowler, C., Kirby, R., Lawrence, W., ... & Watson, G. (1995). A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology, 46(3), 305-310. https://doi.org/10.1016/S0090-4295(99)80211-8

Armitage, J. N., Sibanda, N., Cathcart, P. J., Emberton, M., & van der Meulen, J. H. (2007). Mortality in men admitted to hospital with acute urinary retention: database analysis. Bmj, 335(7631), 1199-1202.

Calogero, A. E., Burgio, G., Condorelli, R. A., Cannarella, R., & La Vignera, S. (2019). Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male, 22(1), 12-19.

Carson III, C., & Rittmaster, R. (2003). The role of dihydrotestosterone in benign prostatic hyperplasia. Urology, 61(4), 2-7. https://doi.org/10.1016/S0090-4295(03)00045-1

Chew, G. T., Gan, S. K., & Watts, G. F. (2006). Revisiting the metabolic syndrome. Medical journal of Australia, 185(8), 445-449.

De Nunzio, C., Brassetti, A., Proietti, F., Deroma, M., Esperto, F., & Tubaro, A. (2018). Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement. Prostate cancer and prostatic diseases, 21(2), 287-292.

Elzayat, E. A., & Elhilali, M. M. (2007). Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. european urology, 52(5), 1465-1472. https://doi.org/10.1016/j.eururo.2007.04.074

Farnham, S. B., Webster, T. M., Herrell, S. D., & Smith Jr, J. A. (2006). Intraoperative blood loss and transfusion requirements for robotic-assisted radical prostatectomy versus radical retropubic prostatectomy. Urology, 67(2), 360-363. https://doi.org/10.1016/j.urology.2005.08.029

Gacci, M., Corona, G., Vignozzi, L., Salvi, M., Serni, S., De Nunzio, C., ... & Maggi, M. (2015). Metabolic syndrome and benign prostatic enlargement: a systematic review and meta?analysis. BJU international, 115(1), 24-31.

Gilling, P. J., Aho, T. F., Frampton, C. M., King, C. J., & Fraundorfer, M. R. (2008). Holmium laser enucleation of the prostate: results at 6 years. European urology, 53(4), 744-749. https://doi.org/10.1016/j.eururo.2007.04.052

Gupta, A., & Gupta, V. (2010). Metabolic syndrome: what are the risks for humans?. Bioscience trends, 4(5).

Jeong, I. G., Hwang, S. S., Kim, H. K., Ahn, H., & Kim, C. S. (2010). The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population. Cancer Epidemiology and Prevention Biomarkers, 19(2), 371-380.

Kupelian, V., McVary, K. T., Kaplan, S. A., Hall, S. A., Link, C. L., Aiyer, L. P., ... & McKinlay, J. B. (2009). Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. The Journal of urology, 182(2), 616-625.

Laraeni, Y., Danuyanti, I. G. A. N., Resnhaleksmana, E., Pauzi, I., Mataram, I. K. A., & Agustini, N. P. (2021). High antioxidant level in cajanus sajan reduces blood glucose level and improves blood lipid profile of rats as diabetes mellitus models. International Journal of Health Sciences, 5(1), 29-37. https://doi.org/10.29332/ijhs.v5n1.725

Lodde, M., Lusuardi, L., Palermo, S., Signorello, D., Maier, K., Hohenfellner, R., & Pycha, A. (2003). En bloc transurethral resection of bladder tumors: use and limits. Urology, 62(6), 1089-1091. https://doi.org/10.1016/S0090-4295(03)00761-1

Lombard, L., Augustyn, M. N., & Ascott-Evans, B. H. (2002). The metabolic syndrome pathogenesis, clinical features and management. Cardiovascular Journal of South Africa, 13(4), 181-186.

Moon, Y. S., Kim, D. H., & Song, D. K. (2004). Serum tumor necrosis factor-? levels and components of the metabolic syndrome in obese adolescents. Metabolism, 53(7), 863-867. https://doi.org/10.1016/j.metabol.2004.02.007

Parekh, N., Lin, Y., Marcella, S., Kant, A. K., & Lu-Yao, G. (2008). Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiology and Prevention Biomarkers, 17(9), 2467-2472.

Sebastianelli, A., & Gacci, M. (2018). Current status of the relationship between metabolic syndrome and lower urinary tract symptoms. European urology focus, 4(1), 25-27.

Shir, Y., Raja, S. N., Frank, S. M., & Brendler, C. B. (1995). Intraoperative blood loss during radical retropubic prostatectomy: epidural versus general anesthesia. Urology, 45(6), 993-999. https://doi.org/10.1016/S0090-4295(99)80120-4

Sivaprakasapillai, B., Edirisinghe, I., Randolph, J., Steinberg, F., & Kappagoda, T. (2009). Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism, 58(12), 1743-1746. https://doi.org/10.1016/j.metabol.2009.05.030

Sulaeman, R., Muhasidah, .-., Purnamawati, D., Zulkifli, .-., Jafar, S. R., & Suiraoka, I. P. (2018). Progressive muscle relaxation using video aids reduces blood pressure of hypertension patients. International Journal of Health Sciences, 2(3), 33-42. https://doi.org/10.29332/ijhs.v2n3.214

Unnikrishnan, R., Almassi, N., & Fareed, K. (2017). Benign prostatic hyperplasia: Evaluation and medical management in primary care. Cleveland Clinic journal of medicine, 84(1), 53-64.

Wilson, J. D. (1980). The pathogenesis of benign prostatic hyperplasia. The American journal of medicine, 68(5), 745-756. https://doi.org/10.1016/0002-9343(80)90267-3

Xu, H., Fu, S., Chen, Y., Chen, Q., Gu, M., & Wang, Z. (2016). Smoking habits and benign prostatic hyperplasia: a systematic review and meta-analysis of observational studies. Medicine, 95(32).

Published

2021-12-28

How to Cite

Rakhmonov, O. M., Shadmanov, A. K., & Juraev, F. M. (2021). Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome. International Journal of Health & Medical Sciences, 5(1), 21-25. https://doi.org/10.21744/ijhms.v5n1.1811

Issue

Section

Peer Review Articles